Biomea Fusion (BMEA) News Today $2.00 -0.18 (-8.26%) Closing price 04:00 PM EasternExtended Trading$1.96 -0.03 (-1.75%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate HighlightsMay 5 at 4:05 PM | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Marshall Wace LLPMarshall Wace LLP decreased its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 49.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 123,313 shares of the company's stock after selling 121,412 shares during the period. Marshall WaMay 5 at 3:35 AM | marketbeat.comAdage Capital Partners GP L.L.C. Sells 400,000 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA)Adage Capital Partners GP L.L.C. trimmed its position in Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 44.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 500,000 shares of the company's stock after selling 400,000 sMay 2 at 4:46 AM | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) Shares Bought by Renaissance Technologies LLCRenaissance Technologies LLC boosted its holdings in Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 317.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 343,732 shares of the company's stock after buying an additional 261,432 shares during the periApril 30, 2025 | marketbeat.comBiomea Fusion (BMEA) to Release Quarterly Earnings on ThursdayBiomea Fusion (NASDAQ:BMEA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-biomea-fusion-inc-stock/)April 30, 2025 | marketbeat.comBiomea Fusion (BMEA) Projected to Post Earnings on ThursdayBiomea Fusion (NASDAQ:BMEA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-biomea-fusion-inc-stock/)April 26, 2025 | marketbeat.comWalleye Capital LLC Takes Position in Biomea Fusion, Inc. (NASDAQ:BMEA)Walleye Capital LLC acquired a new position in Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 235,680 shares of the company's stock, valued at approximatApril 24, 2025 | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Buy" from AnalystsShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have received a consensus rating of "Buy" from the thirteen brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assignApril 22, 2025 | marketbeat.comFY2025 EPS Estimates for Biomea Fusion Cut by HC WainwrightBiomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Research analysts at HC Wainwright decreased their FY2025 earnings per share estimates for shares of Biomea Fusion in a research report issued on Tuesday, April 1st. HC Wainwright analyst J. Pantginis now expects that the company will earn ($3.91)April 5, 2025 | marketbeat.comBarclays Lowers Biomea Fusion (NASDAQ:BMEA) Price Target to $3.00Barclays reduced their price target on shares of Biomea Fusion from $11.00 to $3.00 and set an "equal weight" rating for the company in a report on Wednesday.April 4, 2025 | marketbeat.comHC Wainwright Estimates Biomea Fusion Q1 EarningsBiomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Biomea Fusion in a report released on Tuesday, April 1st. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings per shareApril 3, 2025 | marketbeat.comBarclays Sticks to Their Hold Rating for Biomea Fusion (BMEA)April 2, 2025 | markets.businessinsider.comBiomea Fusion (NASDAQ:BMEA) Issues Quarterly Earnings ResultsBiomea Fusion (NASDAQ:BMEA - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.81) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.00) by $0.19.April 2, 2025 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Announces Quarterly Earnings Results, Beats Estimates By $0.19 EPSBiomea Fusion (NASDAQ:BMEA - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.81) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.00) by $0.19.April 2, 2025 | marketbeat.comBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 1, 2025 | globenewswire.comBiomea Fusion reports Q4 EPS (81c), consensus (93c)April 1, 2025 | markets.businessinsider.comBiomea Fusion's (BMEA) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $40.00 price objective on shares of Biomea Fusion in a report on Monday.April 1, 2025 | marketbeat.comBiomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate HighlightsMarch 31, 2025 | globenewswire.comBiomea Fusion (BMEA) to Release Earnings on MondayBiomea Fusion (NASDAQ:BMEA) will be releasing earnings before the market opens on Monday, April 7, Financial Modeling Prep reports.March 31, 2025 | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Buy" by BrokeragesShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have earned an average recommendation of "Buy" from the thirteen analysts that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assignedMarch 27, 2025 | marketbeat.comBiomea Fusion, Inc.: Biomea Fusion Announces Leadership TransitionMarch 26, 2025 | finanznachrichten.deBiomea Fusion price target lowered to $10 from $50 at OppenheimerMarch 26, 2025 | markets.businessinsider.comBiomea Fusion appoints Mick Hitchcock to succeed Thomas Butler as interim CEOMarch 26, 2025 | msn.comBiomea Fusion names Mick Hitchcock to succeed Thomas Butler as interim CEOMarch 26, 2025 | markets.businessinsider.comBiomea Fusion Names Hitchcock as Interim CEO, Succeeding ButlerMarch 25, 2025 | marketwatch.comBiomea Fusion Announces Leadership TransitionMarch 25, 2025 | globenewswire.comBarclays Sticks to Its Hold Rating for Biomea Fusion (BMEA)March 25, 2025 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for Biomea Fusion (NASDAQ:BMEA)HC Wainwright reissued a "buy" rating and set a $40.00 price target on shares of Biomea Fusion in a report on Monday.March 25, 2025 | marketbeat.comBiomea Fusion announces presentation of icovamenib preclinical, clinical dataMarch 25, 2025 | markets.businessinsider.comIcovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last DoseMarch 24, 2025 | globenewswire.comBiomea Fusion (BMEA) Expected to Announce Quarterly Earnings on MondayBiomea Fusion (NASDAQ:BMEA) will be releasing earnings before the market opens on Monday, March 24, Financial Modeling Prep reports.March 23, 2025 | marketbeat.comBiomea Fusion Insiders Recover Some Losses, Which Stand At US$91kMarch 22, 2025 | finance.yahoo.comD. Boral Capital Reiterates Buy Rating for Biomea Fusion (NASDAQ:BMEA)D. Boral Capital reaffirmed a "buy" rating and set a $16.00 price objective on shares of Biomea Fusion in a report on Wednesday.March 20, 2025 | marketbeat.comBiomea Fusion reports inducement grant under Nasdaq listing ruleMarch 3, 2025 | markets.businessinsider.comBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)March 3, 2025 | globenewswire.comBiomea Fusion to unveil ew icovamenib data at ATTD 2025February 27, 2025 | markets.businessinsider.comBiomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for DiabetesFebruary 27, 2025 | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Down 12.6% in JanuaryBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 10,730,000 shares, a decrease of 12.6% from the January 15th total of 12,280,000 shares. Approximately 33.9% of the shares of the company are sold short. Based on an average daily trading volume, of 802,000 shares, the days-to-cover ratio is currently 13.4 days.February 17, 2025 | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst institutional investors who own 51%February 6, 2025 | finance.yahoo.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of "Buy" by BrokeragesShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have been assigned a consensus recommendation of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, nine have given a buy raFebruary 5, 2025 | marketbeat.comShort Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 6.2%Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 11,540,000 shares, a growth of 6.2% from the December 31st total of 10,870,000 shares. Based on an average daily volume of 891,600 shares, the days-to-cover ratio is currently 12.9 days. Approximately 36.5% of the shares of the company are short sold.February 3, 2025 | marketbeat.comBiomea Fusion’s Strategic Focus on Metabolic Diseases and Promising Pipeline Advances Garner Buy RatingJanuary 14, 2025 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Biomea Fusion (NASDAQ:BMEA)HC Wainwright reiterated a "buy" rating and issued a $40.00 price target on shares of Biomea Fusion in a research note on Tuesday.January 14, 2025 | marketbeat.comBiomea Fusion to become diabetes, obesity medicines companyJanuary 13, 2025 | markets.businessinsider.comBiomea Fusion price target lowered to $16 from $128 at D. Boral CapitalJanuary 13, 2025 | markets.businessinsider.comBiomea Fusion to Become a Diabetes & Obesity Medicines CompanyJanuary 13, 2025 | markets.businessinsider.comBiomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of "Buy" from AnalystsShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have received a consensus rating of "Buy" from the thirteen brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and twJanuary 11, 2025 | marketbeat.comBiomea Fusion's (BMEA) Buy Rating Reaffirmed at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and set a $128.00 price target on shares of Biomea Fusion in a report on Friday.January 10, 2025 | marketbeat.comScotiabank Sticks to Its Buy Rating for Biomea Fusion (BMEA)January 8, 2025 | markets.businessinsider.comBiomea Fusion reports new preclinical data on icovamenib-semaglutide studyJanuary 8, 2025 | markets.businessinsider.com Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address BMEA Media Mentions By Week BMEA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMEA News Sentiment▼1.360.72▲Average Medical News Sentiment BMEA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMEA Articles This Week▼43▲BMEA Articles Average Week Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OLMA News TRDA News BNTC News RNAC News MBX News SEPN News GLUE News PROK News ATAI News ATYR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMEA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMEA Stock Free BMEA Stock Alerts